CircTMC5 promotes GC and sponges miR-361-3p to up-regulate RABL6 expression, thus may have diagnostic and prognostic value in GC. RABL6 also displays therapeutic promise due to its role in the immune regulation of GC.
CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6.